Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,414 JPY | -1.81% | -3.68% | -0.49% |
Sales 2024 * | 35.1B 223M | Sales 2025 * | 39.23B 250M | Capitalization | 127B 809M |
---|---|---|---|---|---|
Net income 2024 * | 1.36B 8.64M | Net income 2025 * | 3.71B 23.61M | EV / Sales 2024 * | 3.31 x |
Net cash position 2024 * | 10.81B 68.85M | Net cash position 2025 * | 12.21B 77.73M | EV / Sales 2025 * | 2.93 x |
P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
24
x | Employees | 350 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.88% |
Latest transcript on Nxera Pharma Co., Ltd.
1 day | -1.81% | ||
1 week | -3.68% | ||
Current month | -3.68% | ||
1 month | -6.23% | ||
3 months | -1.33% | ||
6 months | -2.62% | ||
Current year | -0.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Cargill
CEO | Chief Executive Officer | 40 | 17-09-19 |
Shinichi Tamura
FOU | Founder | 74 | 90-06-21 |
Director of Finance/CFO | - | 22-03-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shinichi Tamura
FOU | Founder | 74 | 90-06-21 |
Noriaki Nagai
BRD | Director/Board Member | 66 | 19-03-26 |
Rolf Soderstrom
BRD | Director/Board Member | 58 | 20-03-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.92% | 20 M€ | -19.95% | ||
1.17% | 14 M€ | -5.30% | ||
0.55% | 19 M€ | +9.76% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1,414 | -1.81% | 623,300 |
24-05-23 | 1,440 | +2.06% | 855,300 |
24-05-22 | 1,411 | -0.14% | 1,001,000 |
24-05-21 | 1,413 | -3.88% | 1,903,600 |
24-05-20 | 1,470 | +0.14% | 961,500 |
Delayed Quote Japan Exchange, May 24, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.49% | 810M | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- 4565 Stock